Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia

Diabetologia

Volumn 53, Issue 2, 2010, Pages 268-276

  Retnakaran, R ^a,b   Qi, Y ^a   Connelly, P W ^b,c   Sermer, M ^a   Hanley, A J ^a,b   Zinman, B ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Adiponectin; Beta cell function; CRP; Gestational diabetes; Leptin; Type 2 diabetes

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; INSULIN; LEPTIN;

ADULT; ARTICLE; CELL FUNCTION; CONCENTRATION (PARAMETERS); DIET RESTRICTION; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BREAST FEEDING; C-REACTIVE PROTEIN; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; ETHNIC GROUPS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LEPTIN; PARITY; POSTPARTUM PERIOD; PREGNANCY; RISK FACTORS; WEIGHT GAIN;

EID: 77949287201     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1600-8     Document Type: Article

References (38)

1. Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. J Clin Invest 115:485-491
2. Feig DS, Zinman B, Wang X, Hux JE (2008) Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179:229-234
3. Buchanan TA (2001) Pancreatic β-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86:989-993
4. Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL (2002) Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 186:751-756
5. Sinha B, Brydon P, Taylor RS et al (2003) Maternal ante-natal parameters as predictors of persistent postnatal glucose intolerance: a comparative study between Afro-Caribbeans, Asians and Caucasians. Diabet Med 20:382-386
6. Albareda M, Caballero A, Badell G et al (2003) Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26:1199-1205
7. Pickup JC, Crook MA (1998) Is type 2 DM a disease of the innate immune system? Diabetologia 41:1241-1248
8. Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64-S73
9. Pradham AD, Manson JE, Rifai N, Buring J, Ridker PM (2001) C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
10. Welsh P, Murray HM, Buckley BM et al (2009) Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care 32:308-310
11. Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179-188
12. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B (2008) Glucose intolerance in pregnancy and future risk of prediabetes or diabetes. Diabetes Care 31:2026-2031
13. Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ (2008) Isolated hyperglycemia at 1-hour on oral glucose tolerance test in pregnancy resembles gestational diabetes in predicting postpartum metabolic dysfunction. Diabetes Care 31:1275-1281
14. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B (2009) The antepartum glucose values that predict neonatal macrosomia differ from those that predict postpartum prediabetes or diabetes: implications for the diagnostic criteria for gestational diabetes. J Clin Endocrinol Metab 94:840-845
15. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057
16. Matsuda M, DeFronzo R (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
18. Wareham NJ, Phillips DI, Byrne CD, Hales CN (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12:931
19. Kahn SE (2003) The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19
20. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B (2004) Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 27:799-800
21. Retnakaran R, Connelly PW, Maguire G, Sermer M, Zinman B, Hanley AJ (2007) Decreased high molecular weight adiponectin in gestational diabetes: implications for the pathophysiology of type 2 diabetes. Diabet Med 24:245-252
22. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R (2003) First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26:819-824
23. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA (2004) Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 89:2306-2311 (Pubitemid 38619868)
24. Winzer C, Wagner O, Festa A et al (2004) Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721-1727
25. Di Benedetto A, Russo GT, Corrado F et al (2005) Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Investig 28:34-38
26. Di Cianni G, Lencioni C, Volpe L et al (2007) C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 23:135-140
27. Catalano PM, Hoegh M, Minium J et al (2006) Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 49:1677-1685
28. Kharroubi I, Rasschaert J, Eizirik DL, Cnop M (2003) Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 312:1118-1122
29. Staiger K, Stefan N, Staiger H et al (2005) Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta cell lipoapoptosis. J Clin Endocrinol Metab 90:6707-6713
30. Okamoto M, Ohara-Imaizumi M, Kubota N et al (2008) Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia 51:827-835
31. Retnakaran R, Hanley AJ, Raif N et al (2005) Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 48:993-1001
32. Bacha F, Saad R, Gungor N, Arslanian SA (2004) Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta cell function. Diabetes Care 27:547-552
33. Guldstrand M, Ahrén B, Adamson U (2004) Improved beta cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab 284:E557-E565
34. Musso G, Gambino R, Biroli G et al (2005) Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 100:2438-2446
35. Koebnick C, Roberts CK, Shaibi GQ et al (2008) Adiponectin and leptin are independently associated with insulin sensitivity, but not with insulin secretion or beta cell function in overweight Hispanic adolescents. Horm Metab Res 40:708-712
36. Clark HD, Graham ID, Karovitch A, Keely EJ (2009) Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am J Obstet Gynecol 200(634): e1-e7
37. Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of pancreatic beta cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796-2803
38. Yu JG, Javorschi S, Hevener AL et al (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese and type 2 diabetic subjects. Diabetes 51:2968-2974